RESUMEN
Subsequent to a human rabies death in Sumter County, South Carolina, we assessed the frequency of exposures to bats in homes and citizens' rabies knowledge. A self-administered survey was mailed to 6033 randomly selected Sumter County addresses. The survey inquired about household exposures to bats and respondents' rabies knowledge. Surveys were returned by mail for descriptive analysis. Of 597 respondents, 3.5% (21/597) reported having bats living in (2.8% or 17/597) or entering their homes (2.5% or 15/597) during 2010-2012. Respondents generally understood that mammals transmit rabies virus through bites, but were less aware of the severity of rabies illness and modern post-exposure vaccine administration. Respondents were unsure about how to exclude bats from homes and ranked highly both healthcare and non-healthcare entities as preferred resources for obtaining assistance with bat-related concerns. We found potential for human exposures to bats in Sumter County households and gaps in citizen knowledge of rabies and bat exclusion. Public health officials should engage non-healthcare partners in assistance disseminating rabies educational materials and for providing appropriate referral for persons potentially exposed to bats.
Asunto(s)
Actitud Frente a la Salud , Quirópteros/virología , Promoción de la Salud , Virus de la Rabia/fisiología , Rabia/prevención & control , Adolescente , Adulto , Anciano , Animales , Mordeduras y Picaduras , Femenino , Humanos , Masculino , Persona de Mediana Edad , Salud Pública , Rabia/virología , South Carolina/epidemiología , Encuestas y Cuestionarios , Adulto Joven , ZoonosisAsunto(s)
Cognición , Diabetes Mellitus Tipo 1/patología , Angiopatías Diabéticas/patología , Hipocampo/patología , Adulto , Atrofia , Atención , Estudios de Casos y Controles , Femenino , Humanos , Hipertensión/patología , Imagen por Resonancia Magnética/métodos , Masculino , Memoria , Persona de Mediana Edad , Pruebas Neuropsicológicas , Desempeño PsicomotorAsunto(s)
Diabetes Mellitus Tipo 1/tratamiento farmacológico , Grasas de la Dieta/administración & dosificación , Hipoglucemia/prevención & control , Hipoglucemiantes/uso terapéutico , Insulina/análogos & derivados , Insulina/uso terapéutico , Adulto , Glucemia/metabolismo , Humanos , Insulina Lispro , Persona de Mediana Edad , Periodo Posprandial , Factores de RiesgoRESUMEN
AIMS: To ascertain whether pre-meal administration of 50% insulin lispro and 50% neutral protamine lispro (NPL), given as a fixed mixture (Humalog Mix50, human soluble (regular) insulin as a basal-bolus regimen in people with Type 1 diabetes. Both regimens included bedtime human isophane (NPH) insulin. METHODS: This was a multinational, multicentre, randomized, open-label, two-period crossover comparison of two insulin treatments for two 12-week periods in 109 patients with Type 1 diabetes. The protocol provided preliminary evaluations of dose requirements and recommendations for insulin dose adjustment when switching regimens on the basis of blood glucose (BG) values. Eight-point BG profiles, frequency of hypoglycaemia, HbA1c, insulin dose, time of injection, and frequency of snacking were assessed during each treatment. RESULTS: Total daily insulin dose was similar for both treatments, but the total pre-meal doses were higher (P < 0.001) and the bedtime dose of isophane was lower (P < 0.001) with Mix50. The pre-meal dose before breakfast and lunch, although statistically different (P = 0.006 and P < 0.001, respectively), was of similar magnitude, but the pre-evening meal dose was higher with Mix50 (P < 0.001). Median (interquartile range) time of insulin injection before meals was: Mix50 4.2 (25th percentile = 1.0; 75th percentile = 6.3) min, human soluble insulin 24.6 (25th percentile = 16.6; 75th percentile = 30.0) min. Pre-meal and bedtime BG concentrations did not differ between treatments. The BG 2 h after the evening meal was lower with Mix50 (8.40 +/- 2.95 mmol/l vs. 9.60 +/- 3.47 mmol/l) (P = 0.049). BG after breakfast and lunch, mean HbA1c, frequency of hypoglycaemia, frequency of snacks, and body weight were not different. CONCLUSION: The use of Mix50 in a basal-bolus regimen achieved similar control of pre-meal BG to human soluble insulin, and overall glycaemic control and hypoglycaemia risk were equivalent. This suggests that Mix50 can provide an adequate supply of insulin to control BG between meals while providing the convenience of injecting immediately before meals.
Asunto(s)
Diabetes Mellitus Tipo 1/tratamiento farmacológico , Hipoglucemiantes/administración & dosificación , Insulina/análogos & derivados , Insulina/administración & dosificación , Protaminas/administración & dosificación , Adulto , Glucemia/análisis , Ritmo Circadiano , Estudios Cruzados , Esquema de Medicación , Femenino , Humanos , Hipoglucemia/tratamiento farmacológico , Hipoglucemia/prevención & control , Insulina Lispro , Insulina de Acción Prolongada , MasculinoRESUMEN
OBJECTIVE: To assess the potential of insulin lispro to limit the frequency of severe hypoglycaemia without compromising glycaemic control in a cohort of patients with type 1 diabetes who are at a high risk of severe hypoglycemia. Research design and methods An open-label, randomised, 12-month comparative crossover study of insulin lispro and regular human insulin was performed in 33 patients with type 1 diabetes with impaired hypoglycaemia awareness. The efficacy of each treatment was evaluated by glycaemic control (HbA(1c)), eight-point home blood glucose profiles, and the frequency and severity of hypoglycaemic episodes and quality of life. RESULTS: Eighteen (55%) patients experienced one or more episodes of severe hypoglycaemia in the 48 weeks of study. There was a trend to a lower incidence of severe hypoglycaemia during treatment with insulin lispro in comparison with regular human insulin (55 vs 84 episodes, p=0.087). This resulted principally from a 47% lower incidence of nocturnal severe hypoglycaemia with insulin lispro (25 vs 47 episodes, p=0.11). The lower frequency of severe hypoglycaemia associated with insulin lispro was not explained by differences in glycated haemoglobin between insulin treatments (HbA(1c) 9.1% insulin lispro vs 9.3% regular human insulin). CONCLUSIONS: In individuals with type 1 diabetes, who have impaired awareness of hypoglycaemia, treatment with insulin lispro may be associated with a lower incidence of severe hypoglycaemia manifested predominantly through less frequent nocturnal episodes. Insulin lispro may have a beneficial role in the management of patients with diabetes at risk of severe hypoglycaemia, although a larger study is required to confirm these findings.
Asunto(s)
Diabetes Mellitus Tipo 1/tratamiento farmacológico , Hipoglucemia/inducido químicamente , Hipoglucemia/diagnóstico , Insulina/análogos & derivados , Insulina/efectos adversos , Percepción , Adulto , Anciano , Estudios Cruzados , Femenino , Hemoglobina Glucada/análisis , Humanos , Insulina/uso terapéutico , Insulina Lispro , Masculino , Persona de Mediana Edad , Calidad de Vida , Encuestas y CuestionariosRESUMEN
OBJECTIVE: Experimentally induced hypoglycemia in humans causes progressive but reversible cognitive dysfunction, but it is not known to what extent neuropsychological tests index abilities of cognitive functioning that are important in everyday life. This study examines the effects of acute insulin-induced hypoglycemia on attention and intelligence in nondiabetic humans. RESEARCH DESIGN AND METHODS: A hyperinsulinemic glucose clamp was used to achieve controlled euglycemia (4.50 [0.22] mmol/l) and hypoglycemia (blood glucose 2.59 [0.19] mmol/l) in 20 healthy volunteers. Subjects were studied on two occasions in a counterbalanced order. During each study condition, subjects completed parallel tests of cognitive function. Cognitive function was assessed by the Test of Everyday Attention and Raven's Progressive Matrices. RESULTS: Hypoglycemia induced a significant deterioration in tests sensitive to both visual and auditory selective attention. During hypoglycemia, attentional flexibility deteriorated and speed of information processing was delayed. Sustained attention was preserved and intelligence scores did not deteriorate during hypoglycemia. CONCLUSIONS: During hypoglycemia, a significant deterioration occurs in attentional abilities, whereas fluid intelligence is preserved. On the basis of these results, it can be surmised that many complex attention tasks relevant to everyday life are impaired during moderate hypoglycemia.
Asunto(s)
Atención , Trastornos del Conocimiento/etiología , Hipoglucemia/complicaciones , Inteligencia , Adulto , Glucemia/análisis , Femenino , Técnica de Clampeo de la Glucosa , Audición , Humanos , Hiperinsulinismo , Masculino , Memoria , Conducta Verbal , Visión OcularRESUMEN
OBJECTIVES: This study aimed to evaluate adherence and identify ways to improve concordance between blood lead testing guidelines and practice. METHODS: One hundred fifty-five pediatricians responded to a questionnaire assessing demographic, knowledge, and attitudinal factors relating to lead testing. RESULTS: Only 27% of the respondents adhered to the guidelines, and less than half knew all of the answers to three factual questions about the recommendations. Adherence was higher among physicians who knew the guidelines, were more recently trained, or had high proportions of Medicaid or minority patients. CONCLUSIONS: Physician education and financial incentives hold the most promise for increasing adherence to blood lead testing guidelines.
Asunto(s)
Actitud del Personal de Salud , Plomo/sangre , Pediatría , Adulto , California , Centers for Disease Control and Prevention, U.S. , Niño , Demografía , Femenino , Humanos , Intoxicación por Plomo/prevención & control , Masculino , Pediatría/estadística & datos numéricos , Guías de Práctica Clínica como Asunto , Encuestas y Cuestionarios , Estados UnidosRESUMEN
Evaluation of the esophagus is helpful in determining the source of chest pain. Eighteen per cent of 72 patients with a normal coronary angiogram had esophageal disease as a source of chest pain. Eight had diffuse esophageal spasm, four had reflux esophagitis and one had an esophageal ulcer. Five of eight patients with diffuse esophageal spasm had relief of symptoms with nitroglycerin. Despite normal coronary arteriogram and normal esophageal manometry 42 of 49 other patients had relief of chest pain with nitroglycerin.